Summary

goalpolo85 Newbie

  • Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients along with factor VIII inhibitors in South korea.
Offline Offline
Posts:
0 (0 per day)
Karma:
+0/-0
Age:
N/A
Date Registered:
May 05, 2024, 04:50:54 AM
Local Time:
May 24, 2024, 07:35:15 PM
Last Active:
May 05, 2024, 06:15:18 AM
Signature:
Our inside vivo examination indicated that there were diurnal differences in the degree of injuries a result of myocardial infarctions, with more dama